Immune mechanisms in allergic eye diseases: What is new?

Current Opinion in Allergy and Clinical Immunology

Volumn 9, Issue 5, 2009, Pages 477-481

  Offiah, Ifeoma ^a   Calder, Virginia L ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Allergic conjunctivitis; CCR3; IL 17; PGE2R; TSLP

Indexed keywords

ANTIALLERGIC AGENT; CYCLOSPORIN A; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 17; INTERLEUKIN 6; LEVOCABASTINE; PEMIROLAST; PROBIOTIC AGENT; STEROID; TACROLIMUS; THYMIC STROMAL LYMPHOPOIETIN;

ANTIINFLAMMATORY ACTIVITY; ATOPIC KERATOCONJUNCTIVITIS; CATARACT; CONJUNCTIVA EPITHELIUM; CORNEA EPITHELIUM; DISEASE SEVERITY; DRUG MECHANISM; EOSINOPHIL; EPITHELIUM CELL; EXPERIMENTAL MODEL; GLAUCOMA; HUMAN; IMMUNE SYSTEM; INTRAOCULAR PRESSURE; LACTOBACILLUS ACIDOPHILUS; MAST CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERENNIAL ALLERGIC CONJUNCTIVITIS; PRIORITY JOURNAL; REVIEW; SEASONAL ALLERGIC CONJUNCTIVITIS; SIDE EFFECT; T LYMPHOCYTE; UNSPECIFIED SIDE EFFECT; VERNAL CONJUNCTIVITIS; VISUAL IMPAIRMENT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; COMPLEMENTARY THERAPIES; CONJUNCTIVA; CONJUNCTIVITIS, ALLERGIC; CORNEA; CYTOKINES; HUMANS; MAST CELLS; PROBIOTICS; T-LYMPHOCYTES; VISION, LOW;

EID: 69749122084     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e3283303e2e     Document Type: Review

References (37)

1. Anderson DF, MacLeod JD, Baddeley SM, et al. Seasonal allergic conjunctivitis is accompanied by increased mast cell numbers in the absence of leukocyte infiltration. Clin Exp Allergy 1997; 27:1060-1066.
2. Bacon AS, McGill JI, Anderson DF, et al. Adhesion molecules and relationship to leukocyte levels in allergic disease. Invest Ophthalmol Vis Sci 1998; 39:322-330. (Pubitemid 28093868)
3. Baddeley S, Bacon AS, McGill JI, et al. Mast cell distribution and neutral protease expression in acute and chronic allergic conjunctivitis. Clin Exp Allergy 1995; 25:41-50.
4. Metz DP, Bacon AS, Holgate ST, Lightman SL. Phenotypic characterization of T cells infiltrating the conjunctiva in chronic allergic eye disease. J Allergy Clin Immunol 1996; 98:686-696. (Pubitemid 26377935)
5. Maggi E, Biswas P, Del Prete G, et al. Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J Immunol 1991; 146:1169-1174.
6. Metz DP, Hingorani M, Calder VL, et al. T cell cytokines in chronic allergic eye disease. J Allergy Clin Immunol 1997; 100:817-824. (Pubitemid 28299002)
7. Leonardi A, DeFranchis G, Zancanaro F, et al. Identification of local Th2 and Th0 lymphocytes in vernal conjunctivitis by cytokine flow cytometry. Invest Ophthalmol Vis Sci 1999; 40:3036-3040. (Pubitemid 29521623)
8. Leonardi A, Sathe S, Bortolotti M, et al. Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients. Allergy 2009; 64:710-717.
9. Abu El-Asrar AM, Struyf S, Al-Kharashi SA, et al. Chemokines in the limbal form of vernal keratoconjunctivitis. Br J Ophthalmol 2000; 84:1360-1366.
10. Abu El-Asrar AM, Struyf S, Al-Mosallam AA, et al. Expression of chemokine receptors in vernal keratoconjunctivitis. Br J Ophthalmol 2001; 85:1357-1361. (Pubitemid 33016120)
11. Abu El-Asrar AM, Struyf S, Al-Kharashi SA, et al. The T lymphocyte chemoattractant Mig is highly expressed in vernal keratoconjunctivitis. Am J Ophthalmol 2003; 136:853-860. (Pubitemid 37330028)
12. Miyazaki D, Nakamura T, Ohbayashi M, et al. Ablation of type I hypersensitivity in experimental allergic conjunctivitis by eotaxin-1/CCR3 blockade. Int Immunol 2009; 21:187-201. In eotaxin-1-deficient mice, there is an ablation of immediate hypersensitivity responses despite mast cell numbers and IgE levels being unchanged. Evidence for a costimulatory role for CCR3 on mast cells is provided.
13. Komatsu N, Miyazaki D, Tominaga T, et al. Transcriptional analyses before and after suppression of immediate hypersensitivity reactions by CCR3 blockade in eyes with experimental allergic conjunctivitis. Invest Ophthalmol Vis Sci 2008; 49:5307-5313.
14. Miyazaki D, Tominaga T, Yakura K, et al. Conjunctival mast cell as a mediator of eosinophilic response in ocular allergy. Mol Vis 2008; 14:1525-1532.
15. Bacon AS, Ahluwalia P, Irani AM, et al. Tear and conjunctival changes during allergen-induced early- and late-phase responses. J Allergy Clin Immunol 2000; 106:948-954. (Pubitemid 30949060)
16. Matsuda A, Okayama Y, Ebihara N, et al. Hyperexpression of the high-affinity IgE receptor-beta chain in chronic allergic keratoconjunctivitis. Invest Ophthalmol Vis Sci 2009; 50:2871-2877.
17. Fukushima A, Sumi T, Ishida W, et al. Endogenous IL-17 does not play a significant role in the development of experimental murine allergic conjunctivitis. Int Arch Allergy Immunol 2008; 147:206-212. IL-17 knockout mice were not inducible for EAC, as other effector cytokines (IL-4, IFNg) were present.
18. Chauhan SK, El Annan J, Ecoiffier T, et al. Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. J Immunol 2009; 182:1247-1252.
19. de Paiva CS, Chotikavanich S, Pangelinan SB, et al. IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol 2009; 2:243-253.
20. Baudouin C, Haouat N, Brignole F, et al. Immunopathological findings in conjunctival cells using immunofluorescence staining of impression cytology specimens. Br J Ophthalmol 1992; 76:545-549.
21. Bonini S, Micera A, Lovieno A, et al. Expression of Toll-like receptors in healthy and allergic conjunctiva. Ophthalmology 2005; 112:1528-1534. (Pubitemid 41725407)
22. Cook EB, Stahl JL, Esnault S, et al. Toll-like receptor 2 expression on human conjunctival epithelial cells: a pathway for Staphylococcus aureus involvement in chronic ocular proinflammatory responses. Ann Allergy Asthma Immunol 2005; 94:486-497. (Pubitemid 40547938)
23. De Saint Jean M, Baudouin C, Di Nolfo M, et al. Comparison of morphological and functional characteristics of primary-cultured human conjunctival epithelium and of Wong-Kilbourne derivative of Chang conjunctival cell line. Exp Eye Res 2004; 2:257-274. (Pubitemid 38077232)
24. Enríquez de Salamanca A, Calder V, Gao J, et al. Cytokine responses by conjunctival epithelial cells: an in vitro model of ocular inflammation. Cytokine 2008; 44:160-167.
25. Cook EB, Stahl JL, Graziano FM, Barney NP. Regulation of the receptor for TNFalpha, TNFR1, in human conjunctival epithelial cells. Invest Ophthalmol Vis Sci 2008; 49:3992-3998.
26. Ying S, O'Connor B, Ratoff J, et al. Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J Immunol 2005; 174:8183-8190. (Pubitemid 40806330)
27. Kato A, Favoreto S Jr, Avila PC, Schleimer RP. TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells. J Immunol 2007; 179:1080-1087.
28. Ueta M, Uematsu S, Akira S, Kinoshita S. Toll-like receptor 3 enhances late-phase reaction of experimental allergic conjunctivitis. J Allergy Clin Immunol 2009; 123:1187-1189. TSLP expression was detected on human conjunctival epithelium and expression of TSLP was induced by polyI:C, via TLR3, at the mRNA and protein levels in primary cultures of normal human conjunctival epithelial cells.
29. Allakhverdi Z, Comeau MR, Jessup HK, et al. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med 2007; 204:253-258. (Pubitemid 46294541)
30. Ma P, Bian F, Wang Z, et al. Human corneal epithelium-derived thymic stromal lymphopoietin: a potential link between the innate and adaptive immune responses via toll-like receptors and Th2 cytokines. Invest Ophthalmol Vis Sci 2009; 50:2702-2709.
31. Ueta M, Matsuoka T, Narumiya S, Kinoshita S. Prostaglandin E receptor subtype EP3 in conjunctival epithelium regulates late-phase reaction of experimental allergic conjunctivitis. J Allergy Clin Immunol 2009; 123:466-471.
32. Ahluwalia P, Anderson DF, Wilson SJ, et al. Nedocromil sodium and levocabastine reduce the symptoms of conjunctival allergen challenge by different mechanisms. J Allergy Clin Immunol 2001; 108:449-454. (Pubitemid 32881069)
33. Fujishima H, Fukagawa K, Tanaka M, et al. The effect of a combined therapy with a histamine H1 antagonist and a chemical mediator release inhibitor on allergic conjunctivitis. Ophthalmologica 2008; 222:232-239.
34. Qasem AR, Bucolo C, Baiula M, et al. Contibution of alpha4beta1 integrin to the anti allergic effect of levocabastine. Biochem Pharmacol 2008; 76:751-762.
35. Anzaar F, Gallagher MJ, Bhat P, et al. Use of systemic T lymphocyte signal transduction inhibitors in the treatment of atopic keratoconjunctivitis. Cornea 2008; 27:884-888.
36. Mainardi T, Kapoor S, Bielory L. Complementary and alternative medicine: herbs, phytochemicals and vitamins and their immunologic effects. J Allergy Clin Immunol 2009; 123:283-294.
37. Lovieno A, Lambiase A, Sacchetti M, et al. Preliminary evidence of the efficacy of probiotic eye-drop treatment in patients with vernal keratoconjunctivitis. Graefes Arch Clin Exp Ophthalmol 2008; 246:435-441. (Pubitemid 351247988)